News

Medicover Genetics showcases impact of research and innovation to EU Commission and Ministry of Finance

In-Cyprus · 2026-07-09

AI SUMMARY

• What happened: Medicover Genetics hosted a delegation from the EU Commission and Cyprus' Ministry of Finance to showcase its contributions to research and innovation in the life sciences sector. • Why it matters: The visit highlighted the role of EU funding in enhancing Cyprus' knowledge-based economy and improving access to advanced diagnostics, which can lead to better patient outcomes and economic growth. • What to watch next: Continued developments in Medicover Genetics' research projects and potential future collaborations between public and private sectors in advancing healthcare innovation in Cyprus.

Business Medicover Genetics showcases impact of research and innovation to EU Commission and Ministry of Finance Eu Delegation Visit 1 Relevant News Medicover Genetics showcases impact of research and innovation to EU Commission and Ministry of Finance 9 July 2026 Bonnie Tyler, Total Eclipse of the Heart singer, dies at 75 9 July 2026 San Fermin festival in Pamplona 9 July 2026 newsroom 9 July 2026 FacebookXWhatsAppEmailPrintViber Medicover Genetics Cyprus welcomed on July 2nd 2026 a delegation from the Directorate-General for Regional and Urban Policy (DG REGIO) of the European Commission and the Directorate General Growth of the Ministry of Finance, comprising Mr Nicolas De Michelis, Deputy Director-General of DG REGIO, Mr Panayiotis Padazatos, Mr Kypros Kyprianou and Mr Charis Soteriou, for a visit focused on the company’s contribution to research, innovation, and the development of Cyprus’ knowledge-based economy. The visit formed part of the Annual Performance Review Meeting of the “THALIA 2021-2027” Cohesion Policy Programme and the European Commission’s on-site visits to projects co-funded under the European Union’s Cohesion Policy in Cyprus. During the visit, the representatives were introduced to Medicover Genetics’ growth journey, its scientific and innovation activities, as well as its research project, co-funded by the EU under the RESTART Research and Innovation Programmes of the Research and Innovation Foundation (RIF), which form part of the Cohesion Policy Programme “THALIA 2021–2027“and its strategic contribution to strengthening Cyprus’ position in the life sciences sector. Through presentations and discussions with the company’s leadership and scientific teams, participants explored the role of European and national funding programmes in accelerating research and innovation, translating scientific knowledge into internationally recognised reproductive genetics and oncology solutions, and creating wider socioeconomic value through improved access to advanced diagnostics, highly skilled employment, and the development of a knowledge-based economy. Public investment achieves its greatest value when it extends beyond supporting research and delivers lasting scientific, societal, and economic impact. Its purpose not only funds innovation, but maximises the return on investment by translating research excellence into solutions that improve lives, strengthen healthcare systems, and reinforce Europe’s competitiveness. Through sustained investment from European, national, and private funding programmes, Medicover Genetics has transformed innovation developed in Cyprus into internationally recognised reproductive genetics and oncology solutions that expand access to highly specialised diagnostics across Europe. By enabling earlier access to important health information, more personalised care, and improved patient outcomes, the company contributes to more equitable healthcare while advancing a knowledge-based economy built on scientific excellence, high-value employment, technological innovation, and international collaboration. This demonstrates how strategic investment in research can generate sustainable socioeconomic value that extends well beyond national borders, benefiting patients, healthcare systems, and society across Europe. Speaking during the visit, Dr Marios Ioannides, Managing Director of Medicover Genetics Cyprus said: “Medicover Genetics Cyprus demonstrates how scientific innovation developed in Cyprus can achieve global impact. The support provided through European, national, and private funding has enabled us to transform research excellence into internationally recognised diagnostic solutions that improve patient care, support highly skilled employment, and strengthen Cyprus’ position as a regional centre for life sciences innovation. We remain committed to investing in research, advancing cutting-edge genomic technologies, and delivering lasting value for patients, healthcare systems, and society.” The visit reaffirmed the importance of close collaboration between the public and private sectors in accelerating innovation, strengthening regional competitiveness, and supporting sustainable economic growth through investments in research, technology, and scientific excellence. Subscribe to our Newsletter Latest News Bonnie Tyler, Total Eclipse of the Heart singer, dies at 75 San Fermin festival in Pamplona Paola Revenioti, Greek LGBTQI+ activist and publisher, dies at 68 Residents describe panic as brawl erupts on Xylophagou road Lawyer arrested for alleged sexual assault of 19-year-old inside drug squad’s office 20 years after historic semi-final run, Marcos Baghdatis lights up Wimbledon again Things to do on Thursday, July 9 Follow en.philenews on Google News and be the first to know all the news about Cyprus and the world.

Source: In-Cyprus
RELATED NEWS

More Stories

All News
News

Cyprus airport traffic decline narrows in June

• What happened: Passenger traffic at Cyprus' Larnaca and Paphos airports declined by 4.11% in June 2026, totaling 1.38 million passengers, a smaller drop ...

News

Volkswagen faces showdown as board meets to consider 100,000 job cuts

• What happened: Volkswagen's supervisory board is meeting to discuss a proposal to cut up to 100,000 jobs and close four German factories amid rising cost...

News

Vassiliko Cement completes dividend payment

• What happened: Vassiliko Cement Works Public Company Ltd has completed its dividend payment of €0.23 per share to eligible shareholders as of July 7, 2026, co...

News

MPs hear that some welfare recipients spend benefit at casinos, betting shops

• What happened: MPs in Cyprus discussed concerns that some recipients of the Minimum Guaranteed Income (EEE) are spending their benefits at casinos and betting...

News

No safe predictions for fuel prices amid Iran war uncertainty, consumer protection chief says

• What happened: The Director of the Consumer Protection Service, Konstantinos Karagiorgis, stated that fuel prices in Cyprus cannot be accurately predicted due...

News

Bonnie Tyler, singer of ‘Total Eclipse of the Heart’, dies at 75

• What happened: Bonnie Tyler, the Welsh singer known for her hit "Total Eclipse of the Heart," has died at the age of 75. • Why it matters: Tyler&#...